{
    "clinical_study": {
        "@rank": "89089", 
        "arm_group": [
            {
                "arm_group_label": "Obstructive sleep apnea patients", 
                "description": "Patients with obstructive sleep apnea that has not received CPAP treatment"
            }, 
            {
                "arm_group_label": "Matched volunteers with non OSA", 
                "description": "Matched volunteers without OSA. Matched in respect to age and BMI"
            }, 
            {
                "arm_group_label": "Matched normal controls with normal BMI", 
                "description": "Volunteers that are matched according to age but has a normal BMI"
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole blood, serum, plasma"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Potential biomarkers for obstructive sleep apnea (OSA), and full genomic screening will be\n      evaluated and correlated to the degree of OSA and to effect of CPAP-treatment measured by\n      polygraphy."
        }, 
        "brief_title": "Evaluation of Potential Biomarkers for Obstructive Sleep Apnea and the Effect of Positive Pressure Treatment", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Obstructive Sleep Apnea", 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "OSA-patients with moderate and severe OSA (n=15+15)\n\n          1. Adult, 18-75 years of age\n\n          2. Moderate (AHI 15-30) or Severe (AHI >30) OSA that are currently untreated and planned\n             for CPAP-treatment\n\n          3. Otherwise healthy except for well controlled hypertension since 3 month, Max BP\n             140/90\n\n          4. Non-smokers\n\n          5. Not pregnant\n\n          6. No medications with antioxidants\n\n          7. BMI of <40\n\n        Controls (AHI<5) Two groups of controls\n\n          1. Matched controls The same age, sex and BMI \u00b1 3 and eventual hypertension. These\n             controls should also fulfill criteria 4-6 above.\n\n          2. Healthy controls with normal BMI (19-25) These controls should also fulfill criteria\n             1., 4-6 above.\n\n        Exclusion Criteria:\n\n          -  If they no not fulfil the inclusion criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "OSA patients will be recruited from an outpatient sleep clinic"
            }
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976052", 
            "org_study_id": "OSABiomarker"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Biomarkers", 
            "Genomics"
        ], 
        "lastchanged_date": "April 2, 2014", 
        "location": {
            "contact": {
                "email": "malin.jonsson.fagerlund@ki.se", 
                "last_name": "Malin Jonsson Fagerlund, MD, PhD", 
                "phone": "+46851772107"
            }, 
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden", 
                    "zip": "SE-17176"
                }, 
                "name": "Department of Anesthesiology, Surgical Sciences and Intensive Care Medicine, Karolinska University Hospital, Solna"
            }, 
            "investigator": {
                "last_name": "Malin Jonsson Fagerlund, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_groups": "3", 
        "overall_contact": {
            "email": "malin.jonsson.fagerlund@ki.se", 
            "last_name": "Malin Jonsson Fagerlund, MD, PhD", 
            "phone": "+46851772107"
        }, 
        "overall_official": {
            "affiliation": "Karolinska University Hospital and Karolinska Institutet", 
            "last_name": "Malin Jonsson Fagerlund, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Biomarkers related to inflammation, hypoxia, oxidative stress, redox and the central nervous system will be measured", 
            "measure": "Biomarker", 
            "safety_issue": "No", 
            "time_frame": "Comparison between 0, 3 and 12 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976052"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska University Hospital", 
            "investigator_full_name": "Malin Jonsson Fagerlund", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Genomic screening by microarray", 
                "measure": "Genomics", 
                "safety_issue": "No", 
                "time_frame": "Comparison between 0, 3, 12 month"
            }, 
            {
                "description": "Apnea hypopnea index at 0, 3 and 12 month after treatment with CPAP in the obstructive sleep apnea groups", 
                "measure": "Apnea hypopnea index", 
                "safety_issue": "No", 
                "time_frame": "Comparision between 0, 3 and 12 month"
            }, 
            {
                "description": "Measurement of exhaled nitric oxide", 
                "measure": "Exhaled nitric oxide", 
                "safety_issue": "No", 
                "time_frame": "Comparision at 0, 3 and 12 month"
            }
        ], 
        "source": "Karolinska University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Karolinska University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}